Serum α-Klotho and SIRT1 - Relationship with graft function, inflammation and hospitalization rates in kidney transplant recipients
Transplant International · 02.06.2026 · 39
DOI: 10.3389/ti.2026.16186 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplant International, online erschienen am 02.06.2026. Verfasst von Anna Sączek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Transplantology, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Kidney Transplantation, Klotho Proteins, Hospitalization, Inflammation. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum.
Abstract (Originalsprache)
Emerging evidence indicates kidney transplant recipients (KTRs) suffer from accelerated cellular aging, low-grade inflammation and variable degrees of allograft dysfunction. These pathobiological processes shape chronic kidney disease in the graft, for which α-Klotho is being explored as a candidate peptide marker for risk stratification. In this observational cohort study, we recruited 127 KTRs in outpatient care at the University Hospital in Kraków, Poland between September 2016 and June 2019. Serum α-Klotho, sirtuin-1 (SIRT1), and high-sensitivity interleukin-6 (hsIL-6) were assayed using ELISA kits in KTRs and 32 healthy controls (HCs). Thereafter, we utilized crude, age-adjusted, and fully adjusted Firth Poisson regression models with robust standard errors to evaluate predictors of all-cause hospitalization. We observed that circulating α-Klotho was reduced in KTRs, as compared with HCs (median 616 vs. 1,042 pg/mL, P < 0.001). Further, α-Klotho was moderately associated with eGFR at baseline (rho = 0.30) and final follow-up (rho = 0.29). In contrast, α-Klotho was inversely correlated with hsIL-6 (rho = −0.39, 95% CI −0.60–0.15, P = 0.002). In multivariable linear regression models, ln (α-Klotho) changes were tied to higher final eGFR (14.8 95% CI 6.2–25.6 mL/min/1.73 m 2 ). During follow-up of 274 person-years, we recorded 153 hospitalizations. In multivariable models, higher ln (α-Klotho) was independently associated with lower hospitalization rate (IRR 0.31, 95% CI 0.15–0.65, P = 0.002). This association persisted after adjustment for baseline eGFR (IRR 0.37, 95% CI 0.20–0.69, P = 0.002). Overall, given further validation and standardization of assay technology, serum α-Klotho may be a strong candidate for supplemental, outpatient risk stratification in KTRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Transplantology, Jagiellonian University Medical College, Kraków, Poland.
Förderung
- Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum
Zitieren
APA
Sączek, A., Batko, K., Banaszkiewicz, M., Małyszko, J., Koc-Żórawska, E., Żórawski, M., Małyszko, J., Niezabitowska, K., Sobczyńska, K., Miarka, P., Bętkowska-Prokop, A., Krzanowska, K., & Krzanowski, M. (2026). Serum α-Klotho and SIRT1 - Relationship with graft function, inflammation and hospitalization rates in kidney transplant recipients. Transplant International, 39. https://doi.org/10.3389/ti.2026.16186
Vancouver
Sączek A, Batko K, Banaszkiewicz M, Małyszko J, Koc-Żórawska E, Żórawski M, et al. Serum α-Klotho and SIRT1 - Relationship with graft function, inflammation and hospitalization rates in kidney transplant recipients. Transplant International. 2026;39. doi:10.3389/ti.2026.16186
BibTeX
@article{Sczek2026,
author = {Sączek, Anna and Batko, Krzysztof and Banaszkiewicz, Małgorzata and Małyszko, Jolanta and Koc-Żórawska, Ewa and Żórawski, Marcin and Małyszko, Jacek and Niezabitowska, Karolina and Sobczyńska, Katarzyna and Miarka, Przemysław and Bętkowska-Prokop, Alina and Krzanowska, Katarzyna and Krzanowski, Marcin},
title = {Serum α-Klotho and SIRT1 - Relationship with graft function, inflammation and hospitalization rates in kidney transplant recipients},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.16186}
}
EUVIMED